Safety and efficacy of drug-coated balloon angioplasty following high-speed rotational atherectomy in calcified coronary lesions

Safety and efficacy of drug-coated balloon angioplasty following high-speed rotational atherectomy in calcified coronary lesions - RotaCut-Sequent study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023017

Enrollment

Registered

2016-07-04

Start date

2016-07-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

calcified coronary stenotic lesions

Interventions

High-speed rotational atherectomy is performed using Rotablator for calcified coronary lesions. Subsequently, drug-coated balloon is used following balloon angioplasty.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Moderate to severe calcified coronary stenotic lesions

Exclusion criteria

Exclusion criteria: 1) Myocardial infarction within 7 days 2) Cardiogenic shock or hemodynamic instability 3) Unprotected left main lesions 4) In-stent restenoses 5) Reference vessel diameter < 2.0 mm 6) No indication for percutaneous coronary intervention 7) Other conditions judged inappropriate by the attending physician

Design outcomes

Primary

Measure	Time frame
Primary procedure success rate Late lumen loss Restenosis rate	—

Countries

Japan

Contacts

Public ContactNaoto Kino

Shiroyama Hospital Cardiovascular Center

kino@shiroyama-hsp.or.jp072-958-1000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026